Michelle L O'Donoghue

19PUBLICATIONS
123CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumoursSocial determinants of healthPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 03, 2026
Safety of low lipoprotein(a) levels: the FOURIER trial.

|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

|May 11, 2026
Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.

|Jan 30, 2026
The year in cardiovascular medicine 2025: the top 10 papers in thrombosis and antithrombotic therapy.

Felicita Andreotti, Michelle L O'Donoghue, Jur Ten Berg

|Nov 03, 2025
Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke.

Victorien Monguillon, Peter J Kelly, Michelle L O'Donoghue

|Sep 25, 2025
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial.

Michelle L O'Donoghue, David A Morrow, Andrea L Vavere

Pageof 4

Frequent Collaborators

11 joint publications

Marc S Sabatine

6 joint publications

Robert P Giugliano

4 joint publications

Nicholas A Marston

4 joint publications

Stephen D Wiviott